File Name: fragile x syndrome diagnosis treatment and research .zip
Since persons with disabilities are one of the groups most affected by the pandemic, and with European Fragile X Syndrome Awareness Day held just a few weeks ago on 10 October, it now seems a good time to recall the Convention on the Rights of Persons with Disabilities, to which the EU is party, and which sets out mandatory standards for the rights of persons with disabilities. I would like to urge the Commission to put all measures in place to guarantee compliance with the obligations contained in Article 4 of the Convention. In that regard:. Is the Commission assessing ways of improving existing techniques for early diagnosis of fragile X syndrome? What tools are being considered to improve care for people with fragile X syndrome? For example, is there a specific budget item for research into this and other diseases? Is there a strategy in place to alleviate job losses among caregivers, health workers, teachers, etc.
Cornelia C. Collectively, this group comprises the 3 faces of fragile X. Even though the 3 conditions share a common genetic defect, each one is a separate health condition that results in a variety of body function impairments such as motor delay, musculoskeletal issues related to low muscle tone, coordination limitations, ataxia, tremor, undefined muscle aches and pains, and, for FXTAS, a late-onset neurodegeneration. Although each FXD condition may benefit from physical therapy intervention, available evidence as to the efficacy of intervention appropriate to FXDs is lacking. This perspective article will discuss the genetic basis of FMR1 gene dysfunction and describe health conditions related to this mutation, which have a range of expressions within a family.
Request PDF | On Jan 1, , L. Bennetto and others published Fragile X syndrome: diagnosis, treatment, and research | Find, read and cite all the research.
Articles in the December issue discuss various health issues affecting school-aged children, including acne, eczema and growth disorders. Volume 46, No. Premutation expansions of the FMR1 gene confer risk for fragile X-associated primary ovarian insufficiency and fragile X-associated tremor ataxia syndrome, as well as other medical and psychiatric comorbidities.
Intellect Dev Disabil 1 August ; 51 4 : — We surveyed professionals in the field of autism to assess their knowledge and perceptions about fragile X syndrome FXS and related issues. Almost half had worked with at least one child diagnosed with FXS, yet most lacked basic knowledge about the condition, underestimated its significance in the etiology of autism spectrum disorders, and rarely accessed fragile X—specific resources. A majority perceived etiology to be an important variable in therapeutic response while three quarters felt that professionals in the field of autism should play an active role in referring children for etiological evaluation. Despite these opinions, most respondents either rarely or never inquired about etiology when working with a new client. The survey results underscore the need for training and education so that autism professionals can become effective partners in diagnostic genetic referral and in research and implementation of syndrome-specific interventions.
Metrics details. Fragile X Syndrome FXS is the second cause of intellectual disability after Down syndrome and the most prevalent cause of intellectual disability in males, affecting — men and — women. It is caused by an alteration of the FMR1 gene, which maps at the Xq The aim of this review was to gather the current clinical and molecular knowledge about FXS to provide clinicians with a tool to guide the initial assessment and follow-up of FXS and to offer to laboratory workers and researchers an update about the current diagnostic procedures. FXS is a well-known condition; however, most of the studies thus far have focused on neuropsychiatric features. Unfortunately, some of the available studies have limitations, such as the paucity of patients enrolled or bias due to the collection of the data in a single-country population, which may be not representative of the average global FXS population. In recent years, insight into the adult presentation of the disease has progressively increased.
Related Editorial. To complement the Annual Clinical Focus on medical genomics, AFP will be publishing a series of short reviews on genetic syndromes. This series was designed to increase awareness of these diseases so that family physicians can recognize and diagnose children with these disorders and understand the kind of care they might require in the future. The first review in this series discusses fragile X syndrome. Fragile X syndrome is caused by an expansion mutation in the Fragile X mental retardation 1 FMR1 gene located on the X chromosome It characteristically leads to some degree of mental retardation. The phenotype is subtle, with minor dysmorphic features and developmental delay during childhood.
Your email address will not be published. Required fields are marked *